CV

CW Ventures

North America, New York, United States, New York

Description

CW Group, a leading manager of medical venture capital funds focused on seed and early stage healthcare investing.

Investor Profile

CW Ventures has made 8 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (25%)
  • Series B (25%)
  • Series D (25%)
  • Series C (13%)
  • Series Unknown (13%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Biopharma
  • Clinical Trials
  • Information Technology
  • Data Integration
  • Pharmaceutical
  • Medical
  • Advanced Materials
  • Computer
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CW Ventures frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Frazier & Associates
North America, Virginia, United States, Staunton
Co-Investments: 2
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 3
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Unilever Ventures
Europe, England, United Kingdom, London
Co-Investments: 2
TIAA
North America, New York, United States, New York
Co-Investments: 2
CalPERS
North America, California, United States, Sacramento
Co-Investments: 2
Venrock
North America, California, United States, Palo Alto
Co-Investments: 5
Intel Capital
North America, California, United States, Santa Clara
Co-Investments: 2
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 6

What are some of recent deals done by CW Ventures?

Surface Logix

Brighton, Massachusetts, United States

Surface Logix is a drug development company using biophysical chemistry to create new small molecule drugs.

BiopharmaBiotechnologyHealth Care
Series DMar 24, 2007
Amount Raised: $19,900,000
Surface Logix

Brighton, Massachusetts, United States

Surface Logix is a drug development company using biophysical chemistry to create new small molecule drugs.

BiopharmaBiotechnologyHealth Care
Series UnknownOct 28, 2005
Amount Raised: $32,000,000
Plexxikon

Berkeley, California, United States

Plexxikon is a engages in the discovery and development of small molecule pharmaceuticals to treat human disease.

BiotechnologyHealth CareMedical
Series BMay 26, 2004
Amount Raised: $46,000,000
Fast Track

San Mateo, California, United States

Fast Track is an information technology company focused on improving and expediting the clinical trials process.

Clinical TrialsHealth CareInformation Technology
Series DMay 9, 2003
Amount Raised: $3,967,000
Surface Logix

Brighton, Massachusetts, United States

Surface Logix is a drug development company using biophysical chemistry to create new small molecule drugs.

BiopharmaBiotechnologyHealth Care
Series CNov 27, 2002
Amount Raised: $25,000,000
Nanosys

Milpitas, California, United States

Nanosys specializes in the development of quantum dot technology for displays.

Advanced MaterialsComputerConsumer ElectronicsElectronicsManufacturingNanotechnology
Series AFeb 11, 2002
Amount Raised: $15,000,000
Amphora Discovery

Durham, North Carolina, United States

Amphora Discovery Corporation operates as a biotechnology company. It provides integrated services to the pharmaceutical industry.

BiotechnologyData IntegrationPharmaceutical
Series ASep 27, 2001
Amount Raised: $35,000,000
Fast Track

San Mateo, California, United States

Fast Track is an information technology company focused on improving and expediting the clinical trials process.

Clinical TrialsHealth CareInformation Technology
Series BApr 5, 2000
Amount Raised: $15,600,000